The release of tumor protein, translationally-controlled 1 (TPT1) by dying cancer cells has been shown to facilitate the recruitment of myeloid-derived suppressor cells (MDSCs) to the tumor microenvironment (TME), thereby promoting local immunosuppression and disease progression (30, 31). Here, TPT1 is linked to neoplasm.